VRTX
Health CareVertex Pharmaceuticals Incorporated
Biotechnology
14-Day MFI Score
38.64
Signal Status
BUY
Signal strength 38% — conviction of the current signal (0–100)
Money Flow Index (14D)
38.64 / 100
Momentum Inflow
Relative Strength vs SPY
-5.6%
20-Day Trend Momentum
Volume Z-Score
-0.25
Volume vs 20-day average (−3σ … +3σ) · normal range
28-Yr Backtest Rank
Top 54.7%
Deterministic Historical Percentile
Daily Bars — VRTX
Latest 13F Institutional Positions
| Institutional Filer | CIK | Shares Held | Quarterly Shift |
|---|---|---|---|
| Bellevue Group AG | 0001674546 | 681,908 | +0.1% |
| Harding Loevner LP | 0000928196 | 313,546 | -20.0% |
| Provident Investment Management, Inc. | 0001076964 | 147,620 | -1.1% |
| Tri Locum Partners LP | 0001826434 | 129,314 | — |
| Jones Hill Capital LP | 0002102314 | 108,603 | — |
Top-5 holders by shares held, latest 13F snapshot (Δshares disclosed per filing). Quarterly shift = % change in position.
Qualitative Tear Sheet
Tear sheet can be requested from our qualitative research AdCho.com
Newsletter signup
Free subscription. Daily trading day morning dispatch. No spam.